Shareholders' Equity (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nov. 22, 2023
USD ($)
$ / shares
shares
|
Jan. 11, 2023 |
Dec. 20, 2021
USD ($)
$ / shares
shares
|
Aug. 16, 2021
USD ($)
$ / shares
|
Dec. 31, 2021
$ / shares
shares
|
Mar. 31, 2021
USD ($)
shares
|
Feb. 28, 2021
USD ($)
shares
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2022
$ / shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Aug. 30, 2023
shares
|
Feb. 22, 2023
₪ / shares
|
Nov. 28, 2013
shares
|
|
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Par value (in New Shekels per share) | (per share) | ₪ 0.25 | ||||||||||||
| Ordinary shares issued for excercise of warrants | 180,000,000 | 93,000,000 | |||||||||||
| Ordinary shares issued to certain consultants | 1,050,000 | ||||||||||||
| fair value for excahnge services (in Dollars) | $ | $ 68 | ||||||||||||
| Securities purchase agreement, description | the Company entered into a securities purchase agreement (the “RD Purchase Agreement”), pursuant to which the Company agreed to sell and issue in a registered direct offering (the “Registered Direct Offering”) an aggregate of 90,000,000 ordinary shares for a purchase price of $0.018 per share (the “RD Shares”) and pre-funded warrants to purchase up to 210,000,000 of the Company’s Ordinary Shares at a purchase price of $0.018 per share and at an immaterial exercise price (the “Pre-funded Warrants”), and, unregistered Series A warrants to purchase up to 300,000,000 Ordinary Shares for an exercise price of $0.02 per shares (the “Series A Warrants”), and unregistered Series B warrants to purchase up to 300,000,000 Ordinary Shares for exercise price of $0.018 per share (the “Series B Warrants”). | the Company completed a registered direct offering with an institutional investor pursuant to which it sold (i) 57,000,000 ordinary shares, and (ii) a pre-funded warrant to purchase 93,000,000 ordinary shares at an offering price of $0.07 per Ordinary share and $0.06 per pre-funded warrant | |||||||||||
| Gross proceeds from offering (in Dollars) | $ | $ 10,000 | ||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.07 | ||||||||||||
| Aggregate number of ADS percentage (in Dollars) | $ | $ 9,997 | ||||||||||||
| Ordinary shares issued | 100,000,000 | 85,000,000 | |||||||||||
| Issuance expenses (in Dollars) | $ | $ 1,307 | ||||||||||||
| Placement agent warrants issued | 10,500,000 | 10,500,000 | |||||||||||
| Initial exercise price per share (in Dollars per share) | $ / shares | $ 0.07 | ||||||||||||
| Stock issuance agreement, description | On December 20, 2021, the Company entered into a warrant exercise agreement (the “Exercise Agreement”) with an institutional investor who is the holder of certain existing warrants to purchase Company’s ordinary shares in a registered direct offering consummated in August 2021. | ||||||||||||
| Aggregate shares | 150,000,000 | ||||||||||||
| Gross proceeds (in Dollars) | $ | $ 3,004 | $ 10,000 | |||||||||||
| Exercise agreement description | The Private Placement Warrants will be immediately exercisable, will expire five years following the effectiveness of an initial resale registration statement registering the ADSs issuable upon the exercise of the warrants, and have an exercise price of $0.07 per Ordinary share. The Company also paid $875 in placement agent fees and issued unregistered placement agent warrants to purchase 10,500,000 Ordinary shares on the same terms as the warrant.Pursuant to the terms of the Exercise Agreements, the holder agreed to exercise the warrants while receiving a-120% warrants coverage, thereby creating a benefit to this warrant holder. As such, the Company recorded a deemed dividend in the amount of $2,590. | ||||||||||||
| Issue of new unregistered warrants | 41,236,500 | 109,091,100 | |||||||||||
| Purchase price per share (in Dollars per share) | $ / shares | $ 0.018 | ||||||||||||
| Exercise price per share (in Dollars per share) | $ / shares | $ 0.067 | ||||||||||||
| Additional paid in capital (in Dollars) | $ | $ 386 | $ 973 | |||||||||||
| Issuance costs (in Dollars) | $ | $ 6,526 | ||||||||||||
| Warrant price per share (in Dollars per share) | $ / shares | $ 0.018 | ||||||||||||
| Ordinary per share issued (in Dollars per share) | $ / shares | $ 0.0183 | ||||||||||||
| Warrants for a total consideration | 589,091,100 | ||||||||||||
| Ordinary shares outstanding | 135,000,000 | ||||||||||||
| Granted excess years | 10 years | ||||||||||||
| Future shares | 100,000,000 | ||||||||||||
| Weighted average remaining contractual life | 5 years 10 months 17 days | 6 years 11 months 15 days | 8 years 5 months 12 days | ||||||||||
| Weighted average grant fair value (in Dollars per share) | $ / shares | $ 0.01 | $ 0.02 | $ 0.18 | ||||||||||
| Compensation costs not yet recognized (in Dollars) | $ | $ 298 | ||||||||||||
| Weighted average remaining contractual terms | 3 years 1 month 6 days | ||||||||||||
| Pre-funded Warrants [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Purchased ordinary shares | 319,091,100 | ||||||||||||
| Ordinary Shares [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Ordinary shares issued for excercise of warrants | 180,000,000 | 50,926,830 | 50,926,830 | 1,050,000 | |||||||||
| Warrants total consideration (in Dollars) | $ | $ 2,744 | $ 2,744 | |||||||||||
| ADS [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Aggregate warrant (in Dollars per share) | $ / shares | $ 150,000,000 | $ 0.022 | |||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.006 | $ 0.07 | |||||||||||
| Ordinary shares issued | 57,000,000 | 57,000,000 | |||||||||||
| Warrant fee and expenses (in Dollars) | $ | $ 700 | ||||||||||||
| Offering expenses and fees (in Dollars) | $ | $ 980 | ||||||||||||
| Issue of new unregistered warrants | 409,091,100 | ||||||||||||
| Warrants exercisable | 1,178,182,200 | ||||||||||||
| Minimum [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Ordinary per share issued (in Dollars per share) | $ / shares | $ 0.02 | ||||||||||||
| Investor price per share (in Dollars per share) | $ / shares | 0.0183 | ||||||||||||
| Maximum [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Ordinary per share issued (in Dollars per share) | $ / shares | 0.005 | ||||||||||||
| Investor price per share (in Dollars per share) | $ / shares | $ 0.00583 | ||||||||||||
| Series A Warrants [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Warrant outstanding | 109,091,100 | ||||||||||||
| A Warrants Purchase [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Exercise price per share (in Dollars per share) | $ / shares | $ 0.02 | ||||||||||||
| A Warrants Purchase [Member] | Private Placement [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Warrant outstanding | 28,636,500 | ||||||||||||
| Series B Warrants [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Warrant outstanding | 109,091,100 | ||||||||||||
| B Warrants Purchase [Member] | |||||||||||||
| Shareholders' Equity (Details) [Line Items] | |||||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 0.018 | ||||||||||||